| 发明名称 |
TAU PROTEIN MEDIATED NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT |
| 摘要 |
The present invention relates to a neurodegenerative disease therapeutic agent, and, more specifically, provides a composition containing, as an active ingredient, an ALK (anaplastic lymphoma kinase) activity or expression inhibiting substance in order to treat a degenerative brain disease caused by the phosphorylation or coagulation of tau proteins. |
| 申请公布号 |
EP2873424(A1) |
申请公布日期 |
2015.05.20 |
| 申请号 |
EP20130794652 |
申请日期 |
2013.05.23 |
| 申请人 |
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
发明人 |
JUNG, YONG KEUN;CHOI, HYUN WOO |
| 分类号 |
A61K39/395;A61K31/4545;A61K31/506;A61K31/7088;A61K31/7105;A61K48/00;A61P25/28;C07K14/705;C07K16/18;C07K16/40;G01N33/50 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
